Topics

Bristol-Myers Squibb’s Opdivo/Yervoy arm of Phase III GEJ cancer drug trial closed due to toxicities, deaths

07:59 EDT 12 Jul 2019 | Pharmaceutical Technology

Bristol-Myers Squibb’s Phase III CheckMate649 trial in first-line gastric and gastroesophageal junction (GEJ) cancer closed its Opdivo (nivolumab) plus Yervoy...
Read More...

The post Bristol-Myers Squibb’s Opdivo/Yervoy arm of Phase III GEJ cancer drug trial closed due to toxicities, deaths appeared first on Pharmaceutical Technology.

Original Article: Bristol-Myers Squibb’s Opdivo/Yervoy arm of Phase III GEJ cancer drug trial closed due to toxicities, deaths

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb’s Opdivo/Yervoy arm of Phase III GEJ cancer drug trial closed due to toxicities, deaths"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...